Read our Director of Regulatory Affairs, Isabella Schmitt, talk about femtech & investments in the recent Innovation Map Article.
Read our Director of Regulatory Affairs, Isabella Schmitt, talk about femtech & investments in the recent Innovation Map Article.
"The concept of femtech shouldn't replace "women's health" which considers broader issues, such as endometriosis and PCOS, as well as other conditions — such as heart disease — common to both men and women but clinically different in the latter. Femtech investors, manufacturers, and health advocates should focus on creating solutions for all issues and diseases that affect women, not just the most obvious."